Bengaluru: OneSource Specialty Pharma Limited, a leading specialty pharma Contract Development and Manufacturing Organization (CDMO), has signed a manufacturing alliance with German-based Formycon AG to produce its biosimilars. According to...
Bengaluru: Biocon Biologics Limited is now a step closer to launching its Aflibercept biosimilar, after gaining approval from the US FDA under the name Yesafili in May 2024. It has...
Mumbai: Donald Trump has slapped a 100% pharma tariff on branded imports. He refers to it as “national security.” For India’s $10 billion pharma export machine, it’s a bitter pill....
New Delhi: Biocon, an Indian pharmaceuticals giant, registered Rs 3,516 crore in revenues for Quarter 1 of FY 2024. An official statement issued by the company said that the profits were...
